Abeona Therapeutics Inc (ABEO)
4.19
-0.26
(-5.84%)
USD |
NASDAQ |
May 10, 13:25
Abeona Therapeutics Free Cash Flow: -37.34M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -37.34M |
| September 30, 2023 | -42.08M |
| June 30, 2023 | -43.09M |
| March 31, 2023 | -41.78M |
| December 31, 2022 | -43.61M |
| September 30, 2022 | -63.10M |
| June 30, 2022 | -67.04M |
| March 31, 2022 | -69.58M |
| December 31, 2021 | -69.82M |
| September 30, 2021 | -37.95M |
| June 30, 2021 | -38.19M |
| March 31, 2021 | -36.67M |
| December 31, 2020 | -36.36M |
| September 30, 2020 | -49.08M |
| June 30, 2020 | -57.30M |
| March 31, 2020 | -66.74M |
| December 31, 2019 | -69.33M |
| September 30, 2019 | -82.84M |
| June 30, 2019 | -74.35M |
| March 31, 2019 | -67.32M |
| December 31, 2018 | -58.60M |
| September 30, 2018 | -36.47M |
| June 30, 2018 | -32.62M |
| March 31, 2018 | -25.17M |
| December 31, 2017 | -23.52M |
| Date | Value |
|---|---|
| September 30, 2017 | -21.18M |
| June 30, 2017 | -18.47M |
| March 31, 2017 | -16.72M |
| December 31, 2016 | -13.53M |
| September 30, 2016 | -13.27M |
| June 30, 2016 | -11.67M |
| March 31, 2016 | -10.30M |
| December 31, 2015 | -10.73M |
| September 30, 2015 | -8.689M |
| June 30, 2015 | -6.29M |
| March 31, 2015 | -4.658M |
| December 31, 2014 | -1.611M |
| September 30, 2014 | -0.984M |
| June 30, 2014 | -1.761M |
| March 31, 2014 | 0.22M |
| December 31, 2013 | -0.001M |
| September 30, 2013 | -1.14M |
| June 30, 2013 | -0.705M |
| March 31, 2013 | -3.219M |
| December 31, 2012 | -3.968M |
| September 30, 2012 | -4.318M |
| June 30, 2012 | -6.834M |
| March 31, 2012 | -7.885M |
| December 31, 2011 | -7.649M |
| September 30, 2011 | -7.401M |
Free Cash Flow Range, Past 5 Years
-82.84M
Minimum
Sep 2019
-36.36M
Maximum
Dec 2020
-54.01M
Average
-49.08M
Median
Sep 2020
Free Cash Flow Benchmarks
| T2 Biosystems Inc | -48.33M |
| INVO Bioscience Inc | -5.200M |
| Perspective Therapeutics Inc | -37.98M |
| Electromed Inc | 3.653M |
| Xtant Medical Holdings Inc | -10.97M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.235M |
| Cash from Investing (Quarterly) | 11.53M |
| Cash from Financing (Quarterly) | 7.467M |
| Free Cash Flow Per Share (Quarterly) | -0.3609 |
| Free Cash Flow Yield | -41.73% |